EUVIMEDEUVIMED entdecken
Crossref

Study of real-World Effectiveness and Tolerability in Indian Patients Receiving Etoricoxib Fast-Disintegrating Tablets for Acute Pain (SWIFT): A Prospective Multicentre Observational Evaluation

Girish Motwani, Braja Kishore Swain, Chandra Kant Ameta, Ashish Srivastava, Sameer Muchhala, Vidhya Natarajan

Fortune Journal of Health Sciences · 2026 · 9 (3)

DOI: 10.26502/fjhs.420 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Fortune Journal of Health Sciences, 2026. Verfasst von Girish Motwani und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Motwani, G., Swain, B. K., Ameta, C. K., Srivastava, A., Muchhala, S., & Natarajan, V. (2026). Study of real-World Effectiveness and Tolerability in Indian Patients Receiving Etoricoxib Fast-Disintegrating Tablets for Acute Pain (SWIFT): A Prospective Multicentre Observational Evaluation. Fortune Journal of Health Sciences, 9(3). https://doi.org/10.26502/fjhs.420

Vancouver

Motwani G, Swain BK, Ameta CK, Srivastava A, Muchhala S, Natarajan V. Study of real-World Effectiveness and Tolerability in Indian Patients Receiving Etoricoxib Fast-Disintegrating Tablets for Acute Pain (SWIFT): A Prospective Multicentre Observational Evaluation. Fortune Journal of Health Sciences. 2026;9(3). doi:10.26502/fjhs.420

BibTeX
@article{Motwani2026,
  author = {Motwani, Girish and Swain, Braja Kishore and Ameta, Chandra Kant and Srivastava, Ashish and Muchhala, Sameer and Natarajan, Vidhya},
  title = {Study of real-World Effectiveness and Tolerability in Indian Patients Receiving Etoricoxib Fast-Disintegrating Tablets for Acute Pain (SWIFT): A Prospective Multicentre Observational Evaluation},
  journal = {Fortune Journal of Health Sciences},
  year = {2026},
  volume = {9},
  number = {3},
  doi = {10.26502/fjhs.420}
}
Kostenlos starten →